Personal information

Activities

Works (4)

Successful monotherapy with autologous formalin‐fixed tumor vaccine for a Stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatment

Clinical Case Reports
2023-06 | Journal article
Contributors: Katsuhiko Fukuda; Tadao Ohno
Source: check_circle
Crossref

A transient increase and subsequent sharp decrease of chemo-refractory liver-metastasized uterine cervical small cell carcinoma to autologous formalin-fixed tumor vaccine plus anti-PD-1 antibody.

2016-07 | Journal article
Contributors: Miyoshi T; Kataoka T; Asahi A; Maruyama T; Okada R; Uemae Y; Ohno T
Source: Self-asserted source
Tadao Ohno via Europe PubMed Central

Cancer Immunotherapy: Comprehensive Mechanism Analysis of Mesoporous-Silica-Nanoparticle-Induced Cancer Immunotherapy (Adv. Healthcare Mater. 10/2016).

2016-05 | Journal article
Contributors: Wang X; Li X; Yoshiyuki K; Watanabe Y; Sogo Y; Ohno T; Tsuji NM; Ito A
Source: Self-asserted source
Tadao Ohno via Europe PubMed Central

Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel-carboplatin therapy responded to autologous formalin-fixed tumor vaccine.

2015-10 | Journal article
Contributors: Chen JT; Ohno T
Source: Self-asserted source
Tadao Ohno via Europe PubMed Central